OPKO Health Inc (OPK)

3.695 0.00  0.00% NASDAQ Oct 22, 16:00 3.66 -0.04  -0.95% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All OPK News

News

View All Events

Events

Date Type Description
10/29/2021 Earnings Results Q3 2021 Earnings Results
10/29/2021 16:30 EST Earnings Calls Q3 2021 Earnings Call
07/29/2021 Earnings Results Q2 2021 Earnings Results
07/29/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
06/24/2021 10:00 EST AGM 2020 Annual General Meeting
04/28/2021 Earnings Results Q1 2021 Earnings Results
04/28/2021 16:30 EST Earnings Calls Q1 2021 Earnings Call
02/18/2021 Earnings Results Q4 2020 Earnings Results
02/18/2021 16:30 EST Earnings Calls Q4 2020 Earnings Call
10/29/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Opko Health is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a specialty active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs.
  • URL: https://www.opko.com
  • Investor Relations URL: https://www.opko.com/investors
  • HQ State/Province: Florida
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Oct. 29, 2021
  • Last Earnings Release: Jul. 29, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
F000014EGS ST Healthcare Innovations 8 F RE 9.69%
SMHCIX ST Healthcare Innovations 9 RE 6.87%
F0000173CB FT Biotechnology 53 CA 3.77%
F00001634C FT Biotechnology 51 CA 3.17%
PBE Invesco Dynamic Biotech & Genome ETF 2.75%
F000016JRW FT Biotechnology 52 F RE 2.70%
F000015MKI FT Biotechnology 50 CA 2.53%
LOPX Direxion Low Priced Stock ETF 2.07%
GERM ETFMG Treatments Testing and Adv ETF 1.53%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.